Inflammopharmacology
Journal Metrics
(Based on the publications from the last 4 years)
(from 2020-10-01 to roughly 2024-10-01)
(from 2020-10-01 to roughly 2024-10-01)
| Number of papers | 799 |
| H4-Index | 29 |
| TQCC | 8 |
| Average citations | 6.855 |
| Median citations | 3 |
| Impact Factor | 4.600 (based on Web of Science 2023) |
(API-Link)
Categories & Ranks
Metric:
(Based on the publications from the last 4 years)
- # 58 / 150 (Q2) in Immunology
- # 22 / 88 (Q1) in Toxicology
Most cited by this journal
(Based on citations to the other journals in the most recent 30 papers in this journal, at least if metadata about citations were available; last updated 2023-05-10)
Impactful Papers
(Based on publications since 2023; last updated 2024-10-28)
What is really ‘Long COVID’?
Inflammopharmacology
2023-03-28
Ad